SCHEDULE 13D/A

Aurinia Pharmaceuticals Inc

Common Shares, no par value · CUSIP: 05156V102

Event date: 2026-03-23

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• TANG CAPITAL MANAGEMENT, LLCReported CIK 0001232621

  Shares: 12,229,500.00 · Class: 9.2%

• KEVIN TANGReported CIK 0001178579

  Shares: 12,229,500.00 · Class: 9.2%

• TANG CAPITAL PARTNERS, LPReported CIK 0001191935

  Shares: 6,990,461.00 · Class: 5.3%

• TANG CAPITAL PARTNERS INTERNATIONAL, LP

  Shares: 5,239,039.00 · Class: 3.9%

• TANG CAPITAL PARTNERS III, INC

  Shares: 0.00 · Class: 0%

• TANG CAPITAL PARTNERS IV, INC

  Shares: 0.00 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.